Evaluating tumor stiffness and adhesion in spinal cord surgery
Preoperative Evaluation of Tumor Stiffness and Adhesion in Spinal Cord Tumor Using Magnetic Resonance Elastography
This study is testing a new imaging technique to see if it can help doctors better understand the stiffness and attachment of spinal cord tumors before surgery, aiming to improve outcomes for patients.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 80 Years |
| Sex | All |
| Sponsor | Shengjing Hospital Academic / other |
| Locations | 1 site (Shenyang, Liaoning) |
| Trial ID | NCT05957679 on ClinicalTrials.gov |
What this trial studies
This clinical trial focuses on the use of magnetic resonance elastography (MRE) to assess the stiffness and adhesion of spinal cord tumors prior to surgical intervention. By measuring these mechanical properties, the study aims to enhance surgical planning and improve outcomes for patients undergoing tumor resection. The trial includes patients with various types of spinal cord tumors and utilizes advanced imaging techniques to provide critical information that standard MRI may not reveal. The goal is to facilitate more precise surgical approaches and minimize risks to surrounding neural tissue.
Who should consider this trial
Good fit: Ideal candidates for this study are patients scheduled for spinal cord tumor resection surgery.
Not a fit: Patients with metallic implants, severe claustrophobia, or those unable to tolerate MRE may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved surgical outcomes and reduced complications for patients with spinal cord tumors.
How similar studies have performed: While the use of MRE in this context is innovative, similar imaging techniques have shown promise in other surgical fields, suggesting potential for success.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing spinal cord tumor resection surgery are eligible for inclusion in the study cohort. Exclusion Criteria: * Patients with metallic implants or foreign bodies in their bodies (pacemakers, artificial metallic heart valves, metal joints, metal implants, and those who cannot remove dentures, insulin pumps, or contraceptive rings) * Pregnant women in the first trimester (within three months) * Patients with severe claustrophobia or anxiety * Patients with severe fever * Patients who can not tolerate MRE * Patients with vascular malformations and aneurysms. * Patients who do not sign an informed consent
Where this trial is running
Shenyang, Liaoning
- Shengjing Hospital — Shenyang, Liaoning, China (Recruiting)
Study contacts
- Principal investigator: Yu Shi, MD — Shengjing Hospital
- Study coordinator: Yu Shi, MD
- Email: 18940259980@163.com
- Phone: +86 189 4025 9980
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.